COVID-19 and hyperglycemia/diabetes

doi:10.4239/wjd.v12.i5.642

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6874)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

479

WORD

202

HTML

3961

Figures (1-2)

260

Sum=4902

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

331

Download

670

Sum=1001

Publishing Process of This Article

Item

Count

Browse

385

Download

586

Sum=971

May 15, 2021 (publication date) through May 28, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. May 15, 2021; 12(5): 642-650
Published online May 15, 2021. doi: 10.4239/wjd.v12.i5.642

Full Size Figure Download Figure

Figure 1 Selected tentative pathways for hyperglycemia in severe acute respiratory syndrome coronavirus 2 infection. ACE2: Angiotensin converting enzyme 2; IL-6: Interleukin 6; ROS: Radical oxygen species; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.

Citation: Michalakis K, Ilias I. COVID-19 and hyperglycemia/diabetes. World J Diabetes 2021; 12(5): 642-650
URL: https://www.wjgnet.com/1948-9358/full/v12/i5/642.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i5.642